Operating Expenses

Amortization of Intangible Assets (Unallocated)

Pfizer Amortization of Intangible Assets (Unallocated) decreased by 2.3% to $1.18B in Q1 2026 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2025
Last reportedQ1 2026
Metric ID: is_pfe_amortization_of_intangible_assets_unallocated

Historical Data

2 periods
 Q1 '25Q1 '26
Value$1.21B$1.18B
QoQ Change—-2.3%
YoY Change—-2.3%
Range$1.18B – $1.21B
Avg YoY Growth-2.3%
Median YoY Growth-2.3%

Frequently Asked Questions

What is Pfizer's amortization of intangible assets (unallocated)?
Pfizer (PFE) reported amortization of intangible assets (unallocated) of $1.18B in Q1 2026.